{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T12:14:52Z","timestamp":1768997692184,"version":"3.49.0"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100007605","name":"Aarhus University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007605","id-type":"DOI","asserted-by":"publisher"}]},{"name":"The Lippman Foundation"},{"name":"Doctor Sofus Carl Emil Friis & Wife Olga Doris Friis Foundation"},{"DOI":"10.13039\/501100003035","name":"Aase & Ejnar Danielsen's Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003035","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Director Werner Richter & Wife Foundation"},{"name":"Danish Society of Anaesthesiology and Intensive Care Foundation"},{"name":"Holger & Ruth Hesse's Memorial Foundation"},{"DOI":"10.13039\/501100008275","name":"Lily Benthine Lund's Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008275","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Letterstedtske Foundation"},{"name":"King Christian the X's Foundation"},{"DOI":"10.13039\/100008322","name":"CSL Behring","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008322","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Octapharma"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thrombosisresearch.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Thrombosis Research"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1016\/j.thromres.2020.02.012","type":"journal-article","created":{"date-parts":[[2020,2,26]],"date-time":"2020-02-26T02:08:13Z","timestamp":1582682893000},"page":"42-47","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Ex vivo effect of hemostatic therapy in subarachnoid and intracerebral hemorrhage"],"prefix":"10.1016","volume":"189","author":[{"given":"Christine Lodberg","family":"Hvas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Signe Voigt","family":"Lauridsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emilie Sandgaard","family":"Pedersen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tua","family":"Gyldenholm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7136-7534","authenticated-orcid":false,"given":"Anne-Mette","family":"Hvas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.thromres.2020.02.012_bb0005","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1186\/s13054-015-1036-0","article-title":"Subarachnoid hemorrhage: who dies, and why?","volume":"19","author":"Lantigua","year":"2015","journal-title":"Crit. Care"},{"issue":"2","key":"10.1016\/j.thromres.2020.02.012_bb0010","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S1474-4422(09)70340-0","article-title":"Incidence, case fatality, and functional outcome of intracerebral haemorrhage over time, according to age, sex, and ethnic origin: a systematic review and meta-analysis","volume":"9","author":"van Asch","year":"2010","journal-title":"Lancet Neurol."},{"issue":"6","key":"10.1016\/j.thromres.2020.02.012_bb0015","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1161\/STR.0b013e3182587839","article-title":"Guidelines for the management of aneurysmal subarachnoid hemorrhage: a guideline for healthcare professionals from the American Heart Association\/american Stroke Association","volume":"43","author":"Connolly","year":"2012","journal-title":"Stroke."},{"issue":"2","key":"10.1016\/j.thromres.2020.02.012_bb0020","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1159\/000346087","article-title":"European Stroke Organization guidelines for the management of intracranial aneurysms and subarachnoid haemorrhage","volume":"35","author":"Steiner","year":"2013","journal-title":"Cerebrovasc. Dis."},{"issue":"10135","key":"10.1016\/j.thromres.2020.02.012_bb0025","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.1016\/S0140-6736(18)31033-X","article-title":"Tranexamic acid for hyperacute primary IntraCerebral Haemorrhage (TICH-2): an international randomised, placebo-controlled, phase 3 superiority trial","volume":"391","author":"Sprigg","year":"2018","journal-title":"Lancet."},{"issue":"20","key":"10.1016\/j.thromres.2020.02.012_bb0030","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1056\/NEJMoa0707534","article-title":"Efficacy and safety of recombinant activated factor VII for acute intracerebral hemorrhage","volume":"358","author":"Mayer","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.thromres.2020.02.012_bb0035","article-title":"Antifibrinolytic therapy for aneurysmal subarachnoid haemorrhage","volume":"8","author":"Baharoglu","year":"2013","journal-title":"Cochrane Database Syst. Rev."},{"issue":"2","key":"10.1016\/j.thromres.2020.02.012_bb0040","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/s12028-011-9581-0","article-title":"Participants in the International Multi-Disciplinary Consensus Conference on the Critical Care Management of Subarachnoid H. Rebleeding after aneurysmal subarachnoid hemorrhage","volume":"15","author":"Starke","year":"2011","journal-title":"Neurocrit. Care."},{"issue":"1","key":"10.1016\/j.thromres.2020.02.012_bb0045","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1097\/WCO.0b013e3283352c01","article-title":"Intracerebral hemorrhage: getting ready for effective treatments","volume":"23","author":"Rincon","year":"2010","journal-title":"Curr. Opin. Neurol."},{"issue":"3","key":"10.1016\/j.thromres.2020.02.012_bb0050","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1161\/STROKEAHA.108.524470","article-title":"Can a subset of intracerebral hemorrhage patients benefit from hemostatic therapy with recombinant activated factor VII?","volume":"40","author":"Mayer","year":"2009","journal-title":"Stroke."},{"issue":"6","key":"10.1016\/j.thromres.2020.02.012_bb0055","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1097\/EJA.0b013e32835f4d5b","article-title":"Management of severe perioperative bleeding: guidelines from the European Society of Anaesthesiology","volume":"30","author":"Kozek-Langenecker","year":"2013","journal-title":"Eur. J. Anaesthesiol."},{"key":"10.1016\/j.thromres.2020.02.012_bb0060","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1186\/s13054-016-1265-x","article-title":"The European guideline on management of major bleeding and coagulopathy following trauma: fourth edition","volume":"20","author":"Rossaint","year":"2016","journal-title":"Crit. Care"},{"key":"10.1016\/j.thromres.2020.02.012_bb0065","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ijoa.2017.03.005","article-title":"An algorithm for the management of coagulopathy from postpartum hemorrhage, using fibrinogen concentrate as first-line therapy","volume":"32","author":"Seto","year":"2017","journal-title":"Int. J. Obstet. Anesth."},{"issue":"10084","key":"10.1016\/j.thromres.2020.02.012_bb0070","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1016\/S0140-6736(17)30638-4","article-title":"Effect of early tranexamic acid administration on mortality, hysterectomy, and other morbidities in women with post-partum haemorrhage (WOMAN): an international, randomised, double-blind, placebo-controlled trial","volume":"389","author":"Collaborators","year":"2017","journal-title":"Lancet."},{"issue":"11","key":"10.1016\/j.thromres.2020.02.012_bb0075","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1161\/CIRCULATIONAHA.113.002283","article-title":"Efficacy and safety of a 4-factor prothrombin complex concentrate in patients on vitamin K antagonists presenting with major bleeding: a randomized, plasma-controlled, phase IIIb study","volume":"128","author":"Sarode","year":"2013","journal-title":"Circulation."},{"issue":"9","key":"10.1016\/j.thromres.2020.02.012_bb0080","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1111\/jth.13772","article-title":"Minimal factor XIII activity level to prevent major spontaneous bleeds","volume":"15","author":"Menegatti","year":"2017","journal-title":"J. Thromb. Haemost."},{"issue":"6","key":"10.1016\/j.thromres.2020.02.012_bb0085","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1111\/j.1538-7836.2011.04269.x","article-title":"The thrombomodulin analog Solulin promotes reperfusion and reduces infarct volume in a thrombotic stroke model","volume":"9","author":"Su","year":"2011","journal-title":"J. Thromb. Haemost."},{"issue":"2","key":"10.1016\/j.thromres.2020.02.012_bb0090","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1160\/TH10-05-0287","article-title":"Phase I study of Solulin, a novel recombinant soluble human thrombomodulin analogue","volume":"105","author":"van Iersel","year":"2011","journal-title":"Thromb. Haemost."},{"issue":"15","key":"10.1016\/j.thromres.2020.02.012_bb0095","doi-asserted-by":"crossref","first-page":"3622","DOI":"10.1182\/blood-2011-11-392308","article-title":"Solulin increases clot stability in whole blood from individuals and dogs with hemophilia","volume":"119","author":"Foley","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2020.02.012_bb0100","doi-asserted-by":"crossref","first-page":"e140","DOI":"10.1016\/j.wneu.2019.06.019","article-title":"Thromboelastometry shows early hypercoagulation in patients with spontaneous subarachnoid hemorrhage","volume":"130","author":"Lauridsen","year":"2019","journal-title":"World Neurosurg."},{"issue":"11","key":"10.1016\/j.thromres.2020.02.012_bb0105","doi-asserted-by":"crossref","first-page":"2951","DOI":"10.1016\/j.jstrokecerebrovasdis.2018.06.022","article-title":"Coagulation profile after spontaneous intracerebral hemorrhage: a cohort study","volume":"27","author":"Lauridsen","year":"2018","journal-title":"J. Stroke Cerebrovasc. Dis."},{"issue":"3","key":"10.1016\/j.thromres.2020.02.012_bb0110","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1161\/STROKEAHA.113.003826","article-title":"Thrombelastography detects possible coagulation disturbance in patients with intracerebral hemorrhage with hematoma enlargement","volume":"45","author":"Kawano-Castillo","year":"2014","journal-title":"Stroke."},{"key":"10.1016\/j.thromres.2020.02.012_bb0115","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.wneu.2016.04.002","article-title":"Thromboelastography parameter predicts outcome after subarachnoid hemorrhage: an exploratory analysis","volume":"96","author":"Ramchand","year":"2016","journal-title":"World Neurosurg."},{"issue":"3","key":"10.1016\/j.thromres.2020.02.012_bb0120","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1046\/j.1538-7836.2003.00075.x","article-title":"Whole blood coagulation thrombelastographic profiles employing minimal tissue factor activation","volume":"1","author":"Sorensen","year":"2003","journal-title":"J. Thromb. Haemost."},{"issue":"1","key":"10.1016\/j.thromres.2020.02.012_bb0125","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1007\/s12035-018-1066-0","article-title":"Changes in the lectin pathway following intracerebral or spontaneous subarachnoid hemorrhage","volume":"56","author":"Sandgaard","year":"2019","journal-title":"Mol. Neurobiol."},{"issue":"7","key":"10.1016\/j.thromres.2020.02.012_bb0130","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1097\/MBC.0000000000000845","article-title":"No hyperfibrinolysis following subarachnoid or intracerebral haemorrhage: a prospective cohort study","volume":"30","author":"Lauridsen","year":"2019","journal-title":"Blood Coagul. Fibrinolysis"},{"issue":"2","key":"10.1016\/j.thromres.2020.02.012_bb0135","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1515\/cclm-2019-0532","article-title":"Plasma neurofilament light chain is associated with mortality after spontaneous intracerebral hemorrhage","volume":"58","author":"Hviid","year":"2020","journal-title":"Clin. Chem. Lab. Med."},{"issue":"1","key":"10.1016\/j.thromres.2020.02.012_bb0140","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1055\/s-0038-1642646","article-title":"The tissue factor pathway: how it has become a \u201cprima ballerina\u201d","volume":"74","author":"Rapaport","year":"1995","journal-title":"Thromb. Haemost."},{"issue":"1","key":"10.1016\/j.thromres.2020.02.012_bb0145","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1055\/s-2005-872853","article-title":"Coagulation factor XIII reduces postoperative bleeding after coronary surgery with extracorporeal circulation","volume":"54","author":"Godje","year":"2006","journal-title":"Thorac. Cardiovasc. Surg."},{"issue":"12","key":"10.1016\/j.thromres.2020.02.012_bb0150","doi-asserted-by":"crossref","first-page":"2976","DOI":"10.1161\/STROKEAHA.110.595868","article-title":"Hemostatic proteins and their association with hematoma growth in patients with acute intracerebral hemorrhage","volume":"41","author":"Marti-Fabregas","year":"2010","journal-title":"Stroke."},{"issue":"5","key":"10.1016\/j.thromres.2020.02.012_bb0155","doi-asserted-by":"crossref","first-page":"e229","DOI":"10.1016\/j.thromres.2012.01.016","article-title":"Reduced clot-stability during the first 6hours after aneurysmal subarachnoid haemorrhage - a prospective case-control study","volume":"129","author":"Larsen","year":"2012","journal-title":"Thromb. Res."},{"issue":"Suppl. 1","key":"10.1016\/j.thromres.2020.02.012_bb0160","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1016\/S0049-3848(99)00078-X","article-title":"Production and composition of prothrombin complex concentrates: correlation between composition and therapeutic efficiency","volume":"95","author":"Hellstern","year":"1999","journal-title":"Thromb. Res."}],"container-title":["Thrombosis Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384820300578?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384820300578?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T17:40:59Z","timestamp":1758735659000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049384820300578"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5]]},"references-count":32,"alternative-id":["S0049384820300578"],"URL":"https:\/\/doi.org\/10.1016\/j.thromres.2020.02.012","relation":{},"ISSN":["0049-3848"],"issn-type":[{"value":"0049-3848","type":"print"}],"subject":[],"published":{"date-parts":[[2020,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ex vivo effect of hemostatic therapy in subarachnoid and intracerebral hemorrhage","name":"articletitle","label":"Article Title"},{"value":"Thrombosis Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.thromres.2020.02.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}